TIMP2 and cancer: In addition, new research indicates that miR-106a has an oncogenic function in the development of pancreatic tumors by facilitating the proliferation, EMT, and invasion of cancer cells by focusing on tissue inhibitors of metalloproteinase 2 (TIMP-2) [122].